NOTICE 1 JUNE 2021 SHARES NEW SHARE FOR TRADING: NETUM GROUP OYJ At the request of Netum Group Oyj, Netum Group Oyj's shares will be traded on
Nasdaq First North Growth Market Finland as from June 2
+46 8 463 83 00
certifiedadviser@penser.se
About Nexstim Plc
Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.
Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.
SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.
Nexstim Oyj: Nexstim Extends Agreement with Canadian Distributor and Receives Order for Three NBT Systems Nexstim or Company ) announces that it has extended its agreement with Canadian Health Solutions group, the Company s distributor in Canada, for an additional five years.
The agreement continues to focus on the distribution of Nexstim s NBT systems for the treatment of Major Depressive Disorder. In conjunction with this extension, the distributor has ordered three NBT systems and corresponding head trackers.
Mikko Karvinen, CEO of Nexstim, comments:
Considering the challenges presented by the global pandemic over the last 14 months, our relationship with Canadian Health Solutions has only strengthened. I am impressed by Dr. David Elias and his competent team and believe this initial order of three systems is only the beginning of providing Canadians with access to the most personalized TMS treatment for depression. There is great opportunity in this partnership.
Company announcement, Helsinki, 21 May 2021 at 3:30 PM (EEST) Share issue / transfer and annulment of shares in connection with reduction of the quantity of shares in Nexstim Plc The Annual General
Investegate announcements from Nexstim Oyj, Share issue / transfer and annulment of shares in connection with reduction of the quantity of shares in Nexstim Plc